Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

SciClone Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00968357

First received: August 27, 2009

Last updated: June 6, 2012

Last verified: June 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2011
Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)